|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities | |||||
| (Accretion) amortization of investment premiums | |||||
| Amortization of financing costs | |||||
| Stock-based compensation | |||||
| Amortization of right-of-use assets | |||||
| Realized gain on investment | |||||
| Interest expense related to operating lease liability | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other current assets | |||||
| Accrued interest, net of interest receivable on maturity of investments | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Lease liability | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of investments | |||||
| Proceeds from sales and maturities of investments | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Public offering, net of offering costs | |||||
| Value of shares withheld related to employee tax withholding | |||||
| Proceeds from warrant and option exercises and stock issuances under employee stock purchase plan | |||||
| ATM offering, net of fees | |||||
| Net cash provided by financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents beginning of period | |||||
| Effect of exchange rate changes on cash | |||||
| Cash and cash equivalents end of period | |||||
| Supplemental disclosure of non-cash investing and financing transactions | |||||
| Unpaid deferred public offering and other financing costs | |||||
| Right-of-use asset obtained in exchange for lease obligation | |||||
Loading...